INSM Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: INSM Shares Outstanding History and INSM YTD Return |
INSM Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: INSM Shares Outstanding History and INSM YTD Return |
INSM Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+37.59% CAGR Mouse over chart for data details
|
INSM Stock Price Chart |
About Insmed Inc |
Insmed is a biopharmaceutical company. Co.'s commercial product, ARIKAYCE, is approved in the U.S. for the treatment of Mycobacterium avium complex lung disease and in Europe for the treatment of nontuberculous mycobacterial lung infections. Co.'s pipelines include: brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis and other neutrophil-mediated diseases; and treprostinil palmitil inhalation powder, an inhaled formulation of the treprostinil prodrug treprostinil palmitil for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. We show 55 historical shares outstanding datapoints in our INSM shares outstanding history coverage, used to compute INSM market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing INSM market cap history over the course of time is important for investors interested in comparing INSM's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of INSM versus a peer is one thing; comparing INSM market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like INSM can fluctuate over the course of history. With this page we aim to empower investors researching INSM by allowing them to research the INSM market cap history. |
INSM Current Stock Quote |
Free INSM Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
INSM Share Performance |
Market Cap Peers |
Insmed (INSM) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
INSP Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.